844 Influenza A surface glycosylation and vaccine design.
http://www.pnas.org/content/114/2/280.abstract
843 Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies.
http://www.nature.com/nm/journal/v22/n12/abs/nm.4201.html
842 A TLR9 agonist promotes IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice.
http://www.nature.com/articles/ncomms13896
841 Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality.
http://www.cell.com/immunity/fulltext/S1074-7613(16)30389-2
840 Epigenomic Profiling of Human CD4+ T Cells Supports a Linear Differentiation Model and Highlights Molecular Regulators of Memory Development
http://www.cell.com/immunity/fulltext/S1074-7613(16)30433-2
839 Macrophage PPARγ, a Lipid Activated Transcription Factor Controls the Growth Factor GDF3 and Skeletal Muscle Regeneration.
http://www.cell.com/immunity/fulltext/S1074-7613(16)30427-7
838 Aggregatibacter actinomycetemcomitans–induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis.
http://stm.sciencemag.org/content/8/369/369ra176
837 Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice.
http://www.pnas.org/content/early/2016/11/22/1617460113.abstract
836 β-cell–mimetic designer cells provide closed-loop glycemic control.
http://science.sciencemag.org/content/354/6317/1296
835 Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months.
http://www.nature.com/articles/ncomms13520
|
